Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases

Area of Science:

• Pharmacology
• Computational Biology
• Drug Development

Background:

• Rare diseases affect millions globally, posing significant drug development challenges due to small patient populations and complex pathophysiology.
• Traditional clinical trial designs are often unfeasible for rare diseases, necessitating innovative approaches.

Purpose of the Study:

• To highlight the potential of Quantitative Systems Pharmacology (QSP) models in accelerating drug development for rare diseases.
• To demonstrate how QSP models can address specific challenges in rare disease drug development through case studies.

Main Methods:

• Utilizing mechanistic Quantitative Systems Pharmacology (QSP) models to represent disease and drug response in virtual patients.
• Simulating disease progression and accounting for phenotypic heterogeneity in virtual patient populations.
• Applying QSP models to various drug modalities, including gene therapy.

Main Results:

• QSP models provide a mechanistic understanding complementing empirical approaches in drug development.
• Case studies demonstrate the value of QSP models in supporting various stages of rare disease drug development.
• QSP models can generate digital twins of patients for mechanistic simulations.

Conclusions:

• QSP models offer a robust framework to overcome inherent challenges in rare disease drug development.
• Increased integration of QSP models into routine drug development is anticipated as applications mature.
• QSP models show promise in expediting the development of therapies for rare indications.